Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female Subjects

NCT02191176 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dextromethorphan syrup - low dose
DRUG: Dextromethorphan syrup - high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim